IBB Among Technology ETFs
End-of-day Nov 20, 2026 · 23 Technology ETFs by 10Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −6.1% | −4.8% | −6.1% | +18.3% | +21.0% | +70.3% | +31.2% | +111.9% | +667.5% |
| Peer average | −5.6% | −11.2% | −14.8% | −18.1% | −5.7% | −2.0% | +47.3% | +12.2% | +330.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$93 of every $1,000 in IBB is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 9.32% | $931.68 | 6.0M | $1.00B |
| 2 | AMGNAmgen | Healthcare | 8.36% | $835.75 | 2.0M | $897.1M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.83% | $782.85 | 1.6M | $840.3M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.63% | $662.99 | 771K | $711.7M |
| 5 | MRNAModerna | Healthcare | 5.28% | $527.54 | 2.8M | $566.3M |
| 6 | ARGXArgenx SE | Healthcare | 3.79% | $379.21 | 432K | $407.0M |
| 7 | NTRANatera | Healthcare | 2.83% | $282.79 | 1.0M | $303.5M |
| 8 | BIIBBiogen | Healthcare | 2.63% | $262.56 | 1.1M | $281.8M |
| 9 | ONCBeone Medicines AG | Healthcare | 2.44% | $243.57 | 654K | $261.4M |
| 10 | INSMInsmed | Healthcare | 2.25% | $225.14 | 1.7M | $241.7M |
| 11 | RVMDRevolution Medicines | Healthcare | 2.23% | $222.66 | 1.5M | $239.0M |
| 12 | ILMNIllumina | Healthcare | 2.19% | $218.93 | 1.2M | $235.0M |
| 13 | GMABGenmab Sponsored | Healthcare | 2.06% | $206.06 | 4.3M | $221.2M |
| 14 | INCYIncyte | Healthcare | 1.69% | $168.62 | 1.6M | $181.0M |
| 15 | UTHRUnited Therapeutics | Healthcare | 1.68% | $167.93 | 322K | $180.3M |
of the $345B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 9.32% |
| 2 | AMGN | Amgen | 8.36% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.83% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.63% |
| 5 | MRNA | Moderna | 5.28% |
| 6 | ARGX | Argenx SE | 3.79% |
| 7 | NTRA | Natera | 2.83% |
| 8 | BIIB | Biogen | 2.63% |
| 9 | ONC | Beone Medicines AG | 2.44% |
| 10 | INSM | Insmed | 2.25% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.0112 |
| Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 20, 2026 | $0.12 |
| Dec 16, 2025 | Dec 19, 2025 | $0.18 |
| Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 21, 2025 | $0.12 |
| Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 30, 2024 | $0.20 |
| Mar 21, 2024 | Mar 27, 2024 | $0.13 |
| Dec 20, 2023 | Dec 27, 2023 | $0.12 |
| Sep 26, 2023 | Oct 2, 2023 | $0.15 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0062 |